Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension
The effectiveness and safety of valsartan have not been assessed in hypertensive children. Therefore, hypertensive patients aged 6 to 16 years (n=261) were randomized to receive weight‐stratified low‐ (10/20 mg), medium‐ (40/80 mg), or high‐dose (80/160 mg) valsartan for 2 weeks. After 2 weeks, pati...
Shranjeno v:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | angleščina |
| Izdano: |
2011
|
| Online dostop: | https://doi.org/10.1111/j.1751-7176.2011.00432.x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|